Zinpentraxin alfa

Modify Date: 2024-04-06 13:52:58

Zinpentraxin alfa Structure
Zinpentraxin alfa structure
Common Name Zinpentraxin alfa
CAS Number 1387453-03-3 Molecular Weight N/A
Density N/A Boiling Point N/A
Molecular Formula N/A Melting Point N/A
MSDS N/A Flash Point N/A

 Use of Zinpentraxin alfa


Zinpentraxin alfa (PRM-151) is a recombinant human pentraxin-2, also known as serum amyloid hSAP, a highly conserved serum protein and soluble pattern recognition receptor (PRR) of the innate immune system that regulates monocyte activation and differentiation. Zinpentraxin alfa inhibits the differentiation of circulating monocytes into fibroblasts and pro-fibroblastic macrophages and suppresses myofibroblast production[1].

 Names

Name Zinpentraxin alfa

 Zinpentraxin alfa Biological Activity

Description Zinpentraxin alfa (PRM-151) is a recombinant human pentraxin-2, also known as serum amyloid hSAP, a highly conserved serum protein and soluble pattern recognition receptor (PRR) of the innate immune system that regulates monocyte activation and differentiation. Zinpentraxin alfa inhibits the differentiation of circulating monocytes into fibroblasts and pro-fibroblastic macrophages and suppresses myofibroblast production[1].
Related Catalog
In Vivo Zinpentraxin alfa(PRM-151)(20 mg/mL,局部 30 μL,每天6 次,连续 5 天或 200 μL 结膜下注射,每隔一天,直到第 8 天)通过局部治疗使家兔前角膜基质中出现大量的肌成纤维细胞标志物α平滑肌肌动蛋白(SMA),然而,在结膜下治疗的家兔角膜中 SMA 肌成纤维细胞的密度显著降低,抑制了肌成纤维细胞的生成[1]。
References

[1]. M R Santhiago, et al. Monocyte development inhibitor PRM-151 decreases corneal myofibroblast generation in rabbits. Exp Eye Res. 2011 Nov;93(5):786-9.  

 Chemical & Physical Properties

No Any Chemical & Physical Properties
The content on this webpage is sourced from various professional data sources. If you have any questions or concerns regarding the content, please feel free to contact service1@chemsrc.com.